Josh Lamstein

Portfolio

Investor Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Josh Lamstein's primary investment focus based on past activity?

Josh Lamstein's primary investment focus, based on available data, is in the Health Tech & Life Sciences sector, as evidenced by his investment in Scopus BioPharma.

When did Josh Lamstein make his first recorded investment?

Josh Lamstein made his first recorded investment in January 2019.

Has Josh Lamstein had any notable exits from his portfolio companies?

Yes, Josh Lamstein had an exit in December 2020 when his portfolio company, Scopus BioPharma, went public on NASDAQ. Scopus BioPharma had raised $3.2M in capital.

What stage of funding does Josh Lamstein typically invest in?

Josh Lamstein has invested in the Seed stage, as seen with his investment in Scopus BioPharma.

Has Josh Lamstein acted as a lead investor in any of his recorded funding rounds?

According to startupim data, Josh Lamstein has not been a lead investor in his recorded funding rounds.

What is the geographic location of Josh Lamstein's headquarters?

Josh Lamstein's headquarters are located in the United States.

Can you name a prominent company in Josh Lamstein's portfolio?

A prominent company in Josh Lamstein's portfolio is Scopus BioPharma, which he invested in in January 2019.